Dergi makalesi Açık Erişim
Sahin, A.; Spiroux, F.; Guedon, I.; Arslan, F. B.; Sarcan, E. T.; Ozkan, T.; Colak, N.; Yuksel, S.; Ozdemir, S.; Ozdemir, B.; Akbas, S.; Ultav, G.; Aktas, Y.; Capan, Y.
{ "conceptrecid": "47802", "created": "2021-03-15T22:07:37.620742+00:00", "doi": "10.1691/ph.2017.7015", "files": [ { "bucket": "7336b6b1-ca36-4e04-b179-b8e6f771c0ad", "checksum": "md5:3ecc68d4fced1ecc933eb56c1eeaff55", "key": "bib-5128784e-8644-40fb-8ca1-ad17346f94a9.txt", "links": { "self": "https://aperta.ulakbim.gov.tr/api/files/7336b6b1-ca36-4e04-b179-b8e6f771c0ad/bib-5128784e-8644-40fb-8ca1-ad17346f94a9.txt" }, "size": 357, "type": "txt" } ], "id": 47803, "links": { "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.1691/ph.2017.7015.svg", "bucket": "https://aperta.ulakbim.gov.tr/api/files/7336b6b1-ca36-4e04-b179-b8e6f771c0ad", "doi": "https://doi.org/10.1691/ph.2017.7015", "html": "https://aperta.ulakbim.gov.tr/record/47803", "latest": "https://aperta.ulakbim.gov.tr/api/records/47803", "latest_html": "https://aperta.ulakbim.gov.tr/record/47803" }, "metadata": { "access_right": "open", "access_right_category": "success", "communities": [ { "id": "tubitak-destekli-proje-yayinlari" } ], "creators": [ { "name": "Sahin, A." }, { "affiliation": "Univ Angers, Fac Pharm, Dept Pharmaceut Technol, Angers, France", "name": "Spiroux, F." }, { "affiliation": "Univ Angers, Fac Pharm, Dept Pharmaceut Technol, Angers, France", "name": "Guedon, I." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Arslan, F. B." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Sarcan, E. T." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Ozkan, T." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Colak, N." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Yuksel, S." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Ozdemir, S." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Ozdemir, B." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Akbas, S." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Ultav, G." }, { "affiliation": "Erciyes Univ, Fac Pharm, Dept Pharmaceut Technol, TR-38070 Kayseri, Turkey", "name": "Aktas, Y." }, { "affiliation": "Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey", "name": "Capan, Y." } ], "description": "In the preparation of nanoparticles (NPs) by the nanoprecipitation method, emulsifiers play a key role for NPs' characteristics. The present study aimed to investigate the combined emulsifier effect on ibuprofen loaded poly( lactic-co-glycolic acid) (PLGA) NPs' characteristics and anticancer activity. Ibuprofen loaded PLGA NPs were prepared by nanoprecipitation using different concentrations of PVA (poly(vinyl alcohol)) or PVA TPGS (d-alpha-tocopherol polyethylene glycol 1000 succinate) combination as emulsifier. It was found that encapsulation efficiencies of NPs varied between 17.9 and 41.9 % and the highest encapsulation efficiency was obtained with 0.5% PVA + 0.1% TPGS (coded as PLGA PVA/TPGS NPs). PLGA PVA/TPGS NPs were characterized and compared with PLGA PVA NPs, which was obtained by 0.5% PVA alone. Polydispersity index of PLGA PVA/TPGS and PLGA PVA NPs were found to be 0.08 and 0.15, respectively. Incorporation of TPGS with PVA slightly decreased the initial ibuprofen release. Transmission electron microscopy analyses demonstrated a nearly uniform particle size distribution and spherical particle shape of the PLGA PVA/TPGS NPs. Additionally, PLGA PVA/TPGS NPs were significantly more cytotoxic than PLGA PVA NPs on the MCF-7 (human breast adenocarcinoma cells) and Caco-2 (human epithelial colorectal adenocarcinoma) cells (p<0.05). Also PLGA PVA/TPGS NPs were not cytotoxic on normal cells (L929, mouse healthy fibroblast cells) (p>0.05). In conclusion, these results indicated that using a combination of TPGS and PVA as an emulsifier in nanoprecipitation could be a promising approach for preparing ibuprofen loaded PLGA NPs because of their improved characteristics and anticancer activity.", "doi": "10.1691/ph.2017.7015", "has_grant": false, "journal": { "issue": "9", "pages": "525-528", "title": "PHARMAZIE", "volume": "72" }, "license": { "id": "cc-by" }, "publication_date": "2017-01-01", "relations": { "version": [ { "count": 1, "index": 0, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "47803" }, "parent": { "pid_type": "recid", "pid_value": "47802" } } ] }, "resource_type": { "subtype": "article", "title": "Dergi makalesi", "type": "publication" }, "title": "Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles" }, "owners": [ 1 ], "revision": 1, "stats": { "downloads": 5.0, "unique_downloads": 5.0, "unique_views": 18.0, "version_downloads": 5.0, "version_unique_downloads": 5.0, "version_unique_views": 18.0, "version_views": 20.0, "version_volume": 1785.0, "views": 20.0, "volume": 1785.0 }, "updated": "2021-03-15T22:07:37.666096+00:00" }
Görüntülenme | 20 |
İndirme | 5 |
Veri hacmi | 1.8 kB |
Tekil görüntülenme | 18 |
Tekil indirme | 5 |